103 related articles for article (PubMed ID: 18936153)
1. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis.
Jiang A; Hu W; Meng H; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):844-50. PubMed ID: 18936153
[TBL] [Abstract][Full Text] [Related]
2. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of murine retinal endothelial cells.
Su X; Sorenson CM; Sheibani N
Mol Vis; 2003 May; 9():171-8. PubMed ID: 12740568
[TBL] [Abstract][Full Text] [Related]
6. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.
Li C; Huang Z; Kingsley R; Zhou X; Li F; Parke DW; Cao W
Arch Ophthalmol; 2007 Jun; 125(6):795-803. PubMed ID: 17562991
[TBL] [Abstract][Full Text] [Related]
7. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of autophagy: a novelly potential therapeutic strategy for retinal neovascularization.
Li R; Tian J; Du J; Zhao L; Yao Y; Yu Z; Chang W; Shi R; Li J
BMC Ophthalmol; 2018 Apr; 18(1):110. PubMed ID: 29703256
[TBL] [Abstract][Full Text] [Related]
10. The role of Vldlr in intraretinal angiogenesis in mice.
Xia CH; Lu E; Liu H; Du X; Beutler B; Gong X
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6572-9. PubMed ID: 21757581
[TBL] [Abstract][Full Text] [Related]
11. Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells.
Zuercher J; Fritzsche M; Feil S; Mohn L; Berger W
Hum Mol Genet; 2012 Jun; 21(12):2619-30. PubMed ID: 22394677
[TBL] [Abstract][Full Text] [Related]
12. Intercapillary bridging cells: immunocytochemical characteristics of cells that connect blood vessels in the retina.
Mendes-Jorge L; Llombart C; Ramos D; López-Luppo M; Valença A; Nacher V; Navarro M; Carretero A; Méndez-Ferrer S; Rodriguez-Baeza A; Ruberte J
Exp Eye Res; 2012 May; 98():79-87. PubMed ID: 22484557
[TBL] [Abstract][Full Text] [Related]
13. Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes.
Yakovlev S; Mikhailenko I; Cao C; Zhang L; Strickland DK; Medved L
Blood; 2012 Jan; 119(2):637-44. PubMed ID: 22096238
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.
Basu A; Menicucci G; Maestas J; Das A; McGuire P
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4974-81. PubMed ID: 19443721
[TBL] [Abstract][Full Text] [Related]
15. Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice.
Johnson V; Xiang M; Chen Z; Junge HJ
PLoS One; 2015; 10(7):e0132013. PubMed ID: 26177550
[TBL] [Abstract][Full Text] [Related]
16. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.
Liu CH; Sun Y; Li J; Gong Y; Tian KT; Evans LP; Morss PC; Fredrick TW; Saba NJ; Chen J
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12163-8. PubMed ID: 26374840
[TBL] [Abstract][Full Text] [Related]
17. HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice.
Kim J; Kim CS; Jo K; Cho YS; Kim HG; Lee GH; Lee YM; Sohn E; Kim JS
Biochem Biophys Res Commun; 2015 Jan; 456(1):53-8. PubMed ID: 25446077
[TBL] [Abstract][Full Text] [Related]
18. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
20. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
